Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

被引:132
作者
Hohlbaum, AM
Gregory, MS
Ju, ST
Marshak-Rothstein, A
机构
[1] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Med, Arthrit Ctr, Boston, MA 02118 USA
[3] Schepens Eye Res Inst, Boston, MA 02114 USA
关键词
D O I
10.4049/jimmunol.167.11.6217
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas ligand (FasL) is a potent proapoptotic type-H transmembrane protein that can cause cell death in Fas(+) target populations. Despite the presumed "silent" nature of apoptotic cell death, forced expression of FasL can induce a dramatic inflammatory response. To elucidate the in vivo mechanism(s) linking FasL and inflammation, we used a membrane-bound cell-free form of FasL (mFasL-vesicle preparation (VP)). We found that i.p. injection of FasL-microvesicles led to the rapid activation and subsequent demise of Mac1(high) resident peritoneal macrophages. Apoptosis of Mac1(high) peritoneal macrophages was observed within 0.5 h of mFasL-VP injection and correlated with the detection of increased macrophage inflammatory protein (MIP)-2 levels in peritoneal lavage fluid as well as induced RNA expression of IL-1 beta, MIP-2, MIP-1 alpha, and MIP-1 beta. In vitro culture of purified peritoneal populations identified Mac1(high) cells as the major cytokine/chemokine producers in response to mFasL-VP. Purified Mac1(high) cells exposed to FasL could restore the ability of Fas-deficient mice to mount an inflammatory response. Our data demonstrate that the FasL-mediated inflammatory response starts with the production of proinflammatory mediators by preapoptotic resident tissue macrophages and suggest a general mechanism responsible for neutrophil inflammation seen in cases of FasL-expressing allografts.
引用
收藏
页码:6217 / 6224
页数:8
相关论文
共 50 条
[1]  
ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147
[2]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[3]   Gene transfer of Fas ligand induces tumor regression in vivo [J].
Arai, H ;
Gordon, D ;
Nabel, EG ;
Nabel, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13862-13867
[4]   TH1 CD4+ LYMPHOCYTES DELETE ACTIVATED MACROPHAGES THROUGH THE FAS/APO-1 ANTIGEN PATHWAY [J].
ASHANY, D ;
SONG, X ;
LACY, E ;
NIKOLICZUGIC, J ;
FRIEDMAN, SM ;
ELKON, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11225-11229
[5]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[6]  
BOZIC CR, 1995, J IMMUNOL, V154, P6048
[7]  
BOZIC CR, 1994, J BIOL CHEM, V269, P29355
[8]   NEUTROPHIL AND B-CELL EXPANSION IN MICE THAT LACK THE MURINE IL-8 RECEPTOR HOMOLOG [J].
CACALANO, G ;
LEE, J ;
KIKLY, K ;
RYAN, AM ;
PITTSMEEK, S ;
HULTGREN, B ;
WOOD, WI ;
MOORE, MW .
SCIENCE, 1994, 265 (5172) :682-684
[9]   Regulation of the proinflammatory effects of Fas ligand (CD95L) [J].
Chen, JJ ;
Sun, YN ;
Nabel, GJ .
SCIENCE, 1998, 282 (5394) :1714-1717
[10]   CLONING AND CHARACTERIZATION OF A CDNA FOR MURINE MACROPHAGE INFLAMMATORY PROTEIN (MIP), A NOVEL MONOKINE WITH INFLAMMATORY AND CHEMOKINETIC PROPERTIES [J].
DAVATELIS, G ;
TEKAMPOLSON, P ;
WOLPE, SD ;
HERMSEN, K ;
LUEDKE, C ;
GALLEGOS, C ;
COIT, D ;
MERRYWEATHER, J ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06) :1939-1944